Clinical Research Directory
Browse clinical research sites, groups, and studies.
GnRH Agonist for Dual Trigger in IVF and for Luteal Phase Support in FET
Sponsor: The University of Hong Kong
Summary
The objectives of this study are to compare the efficacy of the dual trigger group vs the hCG trigger group on the live birth rate in women undergoing IVF and the efficacy of the agonist in LP group vs the placebo group on the live birth rate in women undergoing FET.
Official title: Gonadotrophin Releasing Hormone Agonist for Dual Trigger in in Vitro Fertilization and for Luteal Phase Support in Frozen-thawed Embryo Transfer
Key Details
Gender
FEMALE
Age Range
18 Years - 42 Years
Study Type
INTERVENTIONAL
Enrollment
784
Start Date
2019-09-01
Completion Date
2025-03-30
Last Updated
2024-12-06
Healthy Volunteers
No
Conditions
Interventions
IVF: Decapeptyl and hCG
When at least three follicles reach 18 mm in diameter, recombinant hCG 0.25mg and decapeptyl 0.2mg will be injected subcutaneously.
FET: Decapeptyl
On the day of FET, decapeptyl 0.1 mg will be injected subcutaneously.
IVF: hCG and normal saline
When at least three follicles reach 18 mm in diameter, recombinant hCG 0.25mg and normal saline will be injected subcutaneously.
FET: Normal Saline
On the day of FET, normal saline will be injected subcutaneously.
Locations (1)
Department of Obstetrics and Gynaecology
Hong Kong, Hong Kong, China